» Articles » PMID: 23437223

The Glutathione S-transferase P1 341C>T Polymorphism and Cancer Risk: a Meta-analysis of 28 Case-control Studies

Overview
Journal PLoS One
Date 2013 Feb 26
PMID 23437223
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: GSTP1, which is one major group of the glutathione S-transferase family, plays an important role in the metabolism of carcinogens and toxins, reducing damage of DNA as a suppressor of carcinogenesis. The 341C>T polymorphism of the GSTP1 has been implicated in cancer risk through cutting down its metabolic detoxification activities. However, results from previous studies remain conflicting rather than conclusive. To clarify the correlation and provide more statistical evidence for detecting the significance of 341C>T, a meta-analysis was conducted.

Methodology/principal Findings: The relevant studies were identified through searching of PubMed, Embase, ISI Web of Knowledge and China National Knowledge Infrastructure in August 2012, and selected based on the established inclusion criteria for publications, then a meta-analysis was performed to quantitatively summarize the association of GSTP1 341C>T polymorphism with cancer susceptibility. Stratified analyses were employed to identify the source of heterogeneity. Publication bias was evaluated as well as sensitivity analysis. Based on 28 case-control studies with 13249 cases and 16798 controls, the pooled results indicated that the variant genotypes significantly increased the risk of cancer in homozygote comparison (TT versus CC: P = 0.012, OR = 1.40, 95% CI: 1.08-1.81, P(het.) = 0.575), and recessive model (TT versus CT/CC: P = 0.012, OR = 1.40, 95% CI: 1.08-1.81, P(het.) = 0.562). This was confirmed when stratified analyses were conducted according to ethnicity, source of control, matched control, quality score and cancer types. Moreover, significantly increased risk of cancer was also found in lung cancer (heterozygote comparison and dominant model). The stability of these observations was confirmed by a sensitivity analysis. Begger's funnel plot and Egger's test did not reveal any publication bias.

Conclusions/significance: This meta-analysis suggests that the GSTP1 341C>T polymorphism may contribute to genetic susceptibility to cancer, especially to lung cancer, and in Asian population. Nevertheless, additional well-designed studies focusing on different ethnicity and cancer types are needed to provide a more exact and comprehensive conclusion.

Citing Articles

Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus.

Azarova I, Polonikov A, Klyosova E Int J Mol Sci. 2023; 24(5).

PMID: 36902173 PMC: 10003739. DOI: 10.3390/ijms24054738.


Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokers and the risk of lung cancer.

Kudhair B, Alabid N, Taheri-Kafrani A, Lafta I Mol Biol Rep. 2020; 47(4):2677-2684.

PMID: 32125559 DOI: 10.1007/s11033-020-05359-w.


Comprehensive Analysis of the Association Between the rs1138272 Polymorphism of the GSTP1 Gene and Cancer Susceptibility.

Ding F, Li J, Zhang Y, Qi G, Song Z, Yu Y Front Physiol. 2019; 9:1897.

PMID: 30740061 PMC: 6355699. DOI: 10.3389/fphys.2018.01897.


TLR4 Polymorphisms and Expression in Solid Cancers.

Pandey N, Chauhan A, Jain N Mol Diagn Ther. 2018; 22(6):683-702.

PMID: 30311146 DOI: 10.1007/s40291-018-0361-9.


polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.

Jiang Y, Zhao C, Cheng L, Xu B, Lv H Hered Cancer Clin Pract. 2017; 15:8.

PMID: 28630657 PMC: 5470195. DOI: 10.1186/s13053-017-0068-7.


References
1.
Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P . Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res. 2009; 69(7):2956-65. DOI: 10.1158/0008-5472.CAN-08-2604. View

2.
Liu G, Jiang D, Shen S, Yu L . MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis. Arch Med Res. 2011; 42(2):149-55. DOI: 10.1016/j.arcmed.2011.02.002. View

3.
Gao L, Pan X, Li L, Liang W, Zhu Y, Zhang L . RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2010; 125(3):827-35. DOI: 10.1007/s10549-010-0995-8. View

4.
BECKMAN G, Birgander R, Sjalander A, Saha N, Holmberg P, Kivela A . Is p53 polymorphism maintained by natural selection?. Hum Hered. 1994; 44(5):266-70. DOI: 10.1159/000154228. View

5.
Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View